Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 16, 2018

View Archived Issues

Vertex announces positive results for VX-150 in relief of acute pain

Novel transgelin-2 agonist reduces asthmatic pulmonary resistance in mice

Overall survival improved with OMS-721 in thrombotic microangiopathy trial

siCAG/CUG shown as promising new gene therapy for cancer

Somatic and neurological effects seen with AGT-181 in patients with MPS type I

First-in-human study of ARO-HBV cleared; ARO-AAT granted U.S. orphan status

FDA grants fast track designation to Allecra's AAI-101 in fixed-dose combination with cefepime

TRDN user survey - We want your opinion

FDA approves Makena subcutaneous atuoinjector

Shire reviews key development highlights of fourth quarter 2017

OR51T1 predicts hormone therapy efficacy in men with mHNPC

Intralytix cleared to begin phase I/IIa trials of bacteriophage preparation

Nodthera patents new NLRP3 inflammasome inhibitors

Agios Pharmaceuticals submits NDA for ivosidenib for acute myeloid leukemia

Results from phase III trial of avelumab in advanced NSCLC

Accro Bioscience divulges necrosis inhibitors

Bristol-Myers Squibb Co. presents new TGFBR inhibitors

CARB-X funds Curza's development of Gram-negative antibiotic program

Pfizer patents novel C5a1 receptor antagonists

Sanofi exercises option to license additional multi-specific Nanobodies from Ablynx

New isochroman derivatives presented by Sunovion Pharmaceuticals

FDA accepts Shire's sBLA for the use of Cinryze in children

Miglustat stabilizes ATB-200 in the circulation of Pompe disease patients

Debiopharm Group acquires minority stake in ABAC Therapeutics

Xeris completes two phase III studies of its ready-to-use glucagon rescue pen

Otsuka Pharmaceutical updates pipeline progress of fourth quarter 2017

Daiichi Sankyo seeks Japanese approval of mirogabalin for peripheral neuropathic pain

Genethon begins trial of gene therapy for Crigler-Najjar Syndrome

Miticure approved in Japan for pediatric patients with house dust mite-induced allergic rhinitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...